SPC25 and neoplasm: These findings not only imply that SPC25 could serve as a reliable prognostic biomarker, intricately connected to tumor immunomodulatory mechanisms, but also unveil its potential as a predictor for immunotherapy outcomes in the context of pan-cancer.